Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03950609
Title Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

neuroendocrine tumor

Therapies

Everolimus + Lenvatinib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.